Ernexa Therapeutics (ERNAW) Exchange Rate Effect (2010 - 2020)
Ernexa Therapeutics (ERNAW) reported Exchange Rate Effect of $1000.0 for Q4 2020, down 93.33% on a YoY basis from $15000.0 in Q1 2020, and up 101.41% quarter-over-quarter from -$71000.0 in Q1 2020.
Ernexa Therapeutics (ERNAW) Exchange Rate Effect (2010 - 2020) Analysis & Trends
Ernexa Therapeutics has reported Exchange Rate Effect for 11 years, with the latest figure at $1000.0 in Q4 2020.
- For the quarter ending Q4 2020, Exchange Rate Effect fell 93.33% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2020 stood at -$67000.0 (down 259.52% YoY), and the FY2020 full-year result was $11000.0, down 73.81% from the prior year.
- Exchange Rate Effect for Q4 2020 stood at $1000.0, up from -$71000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $53000.0 in Q1 2016, with the low at -$71000.0 in Q1 2020.
- Historically, Exchange Rate Effect has averaged -$941.18 across 5 years, with a median of $1000.0 in 2020.
- Annual changes were most pronounced in 2017 — Exchange Rate Effect soared 450.0% — and 2018, when it tumbled 571.43%.
- Ernexa Therapeutics' Exchange Rate Effect stood at -$17000.0 in 2016, then jumped by 58.82% to -$7000.0 in 2017, then plunged by 571.43% to -$47000.0 in 2018, then jumped by 131.91% to $15000.0 in 2019, then plunged by 93.33% to $1000.0 in 2020.
- The last three Exchange Rate Effect figures came in at $1000.0 (Q4 2020), -$71000.0 (Q1 2020), and $15000.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Mar 31, 2020 | -71,000.00 |
| Mar 31, 2020 | -71,000.00 |
| Dec 31, 2019 | 15,000.00 |
| Dec 31, 2019 | 15,000.00 |
| Sep 30, 2019 | -12,000.00 |
| Sep 30, 2019 | -12,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Mar 31, 2019 | 19,000.00 |
| Mar 31, 2019 | 19,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Sep 30, 2018 | 21,000.00 |
| Sep 30, 2018 | 21,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Mar 31, 2018 | -25,000.00 |
| Mar 31, 2018 | -25,000.00 |